The findings were consistent with studies on other populations and strongly suggest that further studies of serum HSPA1A in breast cancer are warranted and have the potential to contribute to improved clinical diagnoses, prognosis and treatment of this prevalent malignancy of women. The gene discussed is HSPA1A; the disease is breast cancer.